BioNxt Solutions Closes Second Tranche of Private Placement

BioNxt Solutions Inc. (CSE:BNXT)(OTCQB:XPHYF)(FSE:4XT) has completed the second tranche of its non-brokered private placement. This tranche involved the issuance of 1,000,000 common shares at a price of $0.27 per share, raising $270,000 in gross proceeds. The total offering size is expected to reach up to 6,000,000 shares for maximum gross proceeds of $1,620,000.

The funds will support BioNxt's research, development, commercialization programs, and general working capital. The company also paid a $21,600 cash finder’s fee and issued 80,000 non-transferable common share purchase warrants, exercisable at $0.36 per share for 24 months, to an eligible finder.

All securities from this tranche are subject to a statutory hold period of four months and one day. These securities are not registered under the U.S. Securities Act of 1933 and cannot be offered or sold in the U.S. without registration or an exemption.